$118.52
-2.08 (-1.72%)
At Close: Jul 31, 2026
Best Inverse/Leveraged ETFs of Last Week
02:17pm, Monday, 27'th Nov 2023
Wall Street experienced a four-week winning streak last week.
Healthcare Dashboard, And The Side Effects Of CURE
12:25pm, Thursday, 16'th Nov 2023
Pharmaceuticals/biotechnology and life science tools are close to their historical baseline in value and quality. Healthcare equipment is the most overvalued subsector. Ten healthcare stocks cheaper t
Top Performing Leveraged/Inverse ETFs: 07/23/2023
02:33pm, Tuesday, 25'th Jul 2023
Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
5 Best Inverse/Leveraged ETF Areas of Last Week
09:20am, Monday, 24'th Jul 2023
Wall Street delivered a mixed performance last week due to the steepening of the yield curve.
July Breakout ETF/ETNs Week 29 - 2023: Strongest Momentum Gainers For Next Week
06:51am, Monday, 17'th Jul 2023
This article highlights current and future ETF/ETN breakouts for Week 29 using the MDA momentum cycle model. Following the positive Momentum Gauge signal on June 1st, leading funds include NAIL +67.1%
CURE: One Of Those Rare 3x Leveraged ETFs That Has Delivered Long-Term Returns
12:11pm, Tuesday, 11'th Jul 2023
IXVTR has been one of the best-performing healthcare indices. Investments in a 3x leveraged ETF benchmarking IXVTR can thus provide attractive returns. CURE has been one of those rare 3x leveraged ETF
Healthcare Could Be Showing Signs of a Bullish Summer
12:18pm, Thursday, 29'th Jun 2023
Investors often view healthcare as a safe haven sector, but as market confidence returns, demand for riskier assets could push investors away. However, there could be signs of early summer bullishness
CURE Auto Insurance Goes Live in Claims Operations with Cloverleaf Analytics' Insurance Intelligence Platform
12:55pm, Monday, 05'th Jun 2023
The insurer is better positioned for fast growth after replacing a legacy system and processes with Cloverleaf SAN FRANCISCO, June 5, 2023 /PRNewswire-PRWeb/ — Cloverleaf Analytics (Cloverleaf), the
Top Performing Leveraged/Inverse ETFs: 04/09/2023
02:38pm, Tuesday, 11'th Apr 2023
Top Performing Levered/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Best Inverse/Leveraged ETFs of Last Week
09:07am, Tuesday, 11'th Apr 2023
Wall Street put up a mixed show in the holiday-shortened last week. Leveraged gold miners, healthcare, utilities and energy ETFs/ETNs were among the winning investing areas.
Direxion Daily Healthcare Bull 3x Shares: The CURE / S&P 500 Divergence Is A Tell
12:57am, Friday, 24'th Feb 2023
Launched in June 2011, CURE has a long track record for a leveraged ETF. What makes this 3x leveraged ETF truly unique is its shockingly high multi-year returns.
3 Triple Leveraged ETFs Traders Can Consider in 2023
11:55am, Monday, 09'th Jan 2023
The default play for traders in 2023 may be to simply bet on sectors that were hit the hardest in 2022 and hope for a dead cat bounce. However, in a market still full of unknowns, some precaution is n
Rising Healthcare Costs Put This Leveraged ETF Into Perspective
07:06pm, Thursday, 18'th Aug 2022
Inflation hasn't been the only thing going up as of late. Rising healthcare costs have also been hitting consumers, putting the Direxion Daily Healthcare Bull 3X ETF (CURE) in perspective for trader
Despite Recent Weakness, Fundamentals Still Strong for Healthcare
11:20am, Thursday, 07'th Jul 2022
Equities across the board haven't been safe from the downward sell-off pressure. That also goes for healthcare, which is typically steady in times of volatility.
Hedge Forecast Price Ranges For CURE, Healthcare ETFs And Stocks
01:22pm, Thursday, 30'th Jun 2022
Risk-avoidance for Market-Makers required in filling volume “block trade” market orders, these hedging-derived prices are not just single-point “targets”. Their highs and lows are expected lim
Sign In
Buy CURE